Pharmaceutical

Attovia secures $105m to advance development of lead programmes

Attovia Therapeutics has secured $105m in a Series B financing round to expedite the development of its lead programmes.

May 11, 2024 - 04:00
Attovia secures $105m to advance development of lead programmes
Attovia Therapeutics has secured $105m in a Series B financing round to expedite the development of its lead programmes.
Read the original article

Tags:

Previous Article

Four ways the vaccine rush will define infectious disease trends for CROs in 2024

Next Article

Novo Nordisk enters deal to develop obesity therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Pfizer boasts over 30% increase in Q3 revenues against previous year

Pfizer boasts over 30% increase in Q3 revenues against ...

Nov 1, 2024

STAT+: Medicare’s new pay boost for primary care is angering specialists

STAT+: Medicare’s new pay boost for primary care is ang...

Nov 11, 2023

Sanofi’s $17bn sale of Opella to US investors advances following government deal

Sanofi’s $17bn sale of Opella to US investors advances ...

Oct 22, 2024